dihexa safety Capsules Dihexa | Research Scientific Ltd

doi:10.1002/jor.21107 Evidence-Base Disclosure The published evidence base for BPC-157 consists predominantly of preclinical research animal models (often rats or mice) and in vitro cell-culture experiments

Dr MJ says the whole world should get this one

Every report also comes with a review from a qualified doctor to help you understand what your results mean

Early human signalsincluding the first oral evaluationshowing directional improvements in pain metrics with excellent short-term tolerability

The safety profile, and efficacy of BPC-157 peptide is still yet to be determined by the drug administration agency and FDA before it is approved as a therapeutic agent for human consumption

In a 2019 study published in the European Journal of Pharmacology, BPC-157 administration in rats receiving warfarin resulted in 34% longer bleeding times compared to warfarin alone